Clinical Trials in Minneapolis

Showing 6181-6200 of 14,456 trials

P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris

NCT02242760

This is a randomized, multi-center, double-blinded study in subjects with moderate to severe acne vulgaris. Subjects eligible to enroll will be treated once or twice daily with 2 concentrations of a topical drug in development or a vehicle. Subjects will be treated for up to 12 weeks.

Acne Vulgaris

Novan, Inc.213 participantsStarted Nov 2014

Hot Springs, Arkansas, United States • Encinitas, California, United States • San Diego, California, United States +17 more locations

TERMINATEDPhase 1< 1 mile

A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT05077423

Pediatric patients (\<21 years at study entry) with relapsed or refractory acute myeloid leukemia (AML) will be treated with CD33\*CD3 a bispecific antibody to investigate the safety and tolerability of the drug.

AML, Childhood

Y-mAbs Therapeutics3 participantsStarted May 2022

Birmingham, Alabama, United States • Orange, California, United States • San Francisco, California, United States +10 more locations

P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris

A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

Find Trials by Condition in Minneapolis

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer

Dimethyl Fumarate (DMF) Observational Study

S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

Food Related Video and the Incidence of Postoperative Nausea and Vomiting

Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis

A Study to Assess S-217622 in Participants With Mild and Moderate Hepatic Impairment and Healthy Control Participants

Air Optix Night and Day Aqua (AONDA) Retrospective Study 1

Single-Ascending Dose Study of JK07 in Subjects With HFpEF

A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B

Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)

Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer

To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue

Study of Diroximel Fumarate in the Real-World Setting

Thrombosomes® in Bleeding Thrombocytopenic Patients Study

Implementing Personal Health Records to Promote Evidence-Based Cancer Screening

Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)

Therapeutic Antibodies Against Prion Diseases From PRNP Mutation Carriers